Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Cancer Research|March 31, 2001
Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinaseM Yasuda, Y Tanaka, M Tamura, et al.International Journal of Clinical Oncology|November 15, 2001
Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytesR Eifuku, M Takenoyama, I Yoshino, et al.Journal of UOEH|September 26, 2001
[Results of surgical treatment for primary lung cancer; time trends of survival and clinicopathologic features]T Osaki, T Oyama, M Takenoyama, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|November 12, 2010
[Surgical treatment for patients with descending necrotizing mediastinitis]S Oka, T Hanagiri, M Takenaka, et al.Japanese Journal of Cancer Research : Gann|March 24, 1998
Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cellsM Takenoyama, I Yoshino, H Fujie, et al.British Journal of Cancer|January 22, 2004
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrenceC Gu, T Oyama, T Osaki, et al.Immunopharmacology and Immunotoxicology|November 1, 1995
Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang)M Harada, K Seta, O Ito, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Th1 type CD4+ T cells may be a potent effector against poorly immunogenic syngeneic tumorsH Terao, M Harada, S Kurosawa, et al.Thorax|December 20, 2000
Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancerH Uramoto, R Nakanishi, Y Fujino, et al.Japanese Journal of Clinical Oncology|September 28, 2000
Heterogeneous response patterns of alveolar macrophages from patients with lung cancer by stimulation with interferon-gammaR Eifuku, T Yoshimatsu, I Yoshino, et al.Pageof 5